We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Method Developed to Detect AFP and GP73 Simultaneously

By LabMedica International staff writers
Posted on 05 Jun 2018
Print article
Image: The Luminex 200 System is a flexible analyzer based on the principles of flow cytometry (Photo courtesy of Luminex).
Image: The Luminex 200 System is a flexible analyzer based on the principles of flow cytometry (Photo courtesy of Luminex).
Liver cancer is the second leading cause of cancer death in males and the sixth in females worldwide. An estimated 782,500 new liver cancer cases and 745,500 deaths occurred worldwide during 2012.

Alpha-fetoprotein (AFP) is a biomarker that is commonly used in the clinic for Hepatocellular Carcinoma (HCC) diagnosis and to predict HCC progression especially in chronic hepatitis B (HBV) infected patients. Golgi protein 73 (GP73) is a biomarker for advanced liver diseases and the increase in GP73 levels is correlated with various liver diseases.

Scientists at Capital Medical University, Beijing, PR China) used anti-human AFP and GP73 monoclonal antibodies to develop a sandwich immunity reaction using xMAP technology for the simultaneous detection of plasma AFP and GP73. The assay evaluated the sensitivity, cross reactivity, range of detection, precision, recovery and linearity dilution effect. The assay utilized plasma samples and compared its performance with commercially available Enzyme Linked Immunosorbent Assay (ELISA) kits. The team used the Luminex-200 analyzer and the iMark microplate reader.

The scientists analyzed 80 clinical plasma samples using the Luminex multiplex assay system and commercially available ELISA kits. The correlation coefficient of AFP and GP73 were 0.997 and 0.959 respectively. The results showed that the AFP levels from HCC patient samples were significantly higher than from patient samples with liver cirrhosis and healthy controls. However, AFP levels in patients with liver cirrhosis were not significantly different from that of healthy controls. The GP73 levels of samples from HCC and liver cirrhosis patients were significantly higher than healthy controls; however, the GP73 levels from patients with HCC and liver cirrhosis were not significantly different.

The authors concluded that they have established a new method to detect AFP and GP73 levels in plasma samples simultaneously using the Luminex xMAP technology. The method demonstrated a sensitive, effective, and accurate method and the assay could be used clinically for routine detection and monitoring of patients with HBV related diseases. The study was published in the July 2018 issue of the journal Clinica Chimica Acta.

Related Links:
Capital Medical University

New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Nuclear Matrix Protein 22 Test
NMP22 Test
New
Human Insulin CLIA
Human Insulin CLIA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.